we report the outcomes of the 20 SVT paztients who were treated with PEG
A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis / Mascarenhas J.; Kosiorek H.; Prchal J.; Yacoub A.; Berenzon D.; Baer M.R.; Ritchie E.; Silver R.T.; Kessler C.; Winton E.; Finazzi M.C.; Rambaldi A.; Vannucchi A.M.; Leibowitz D.; Rondelli D.; Arcasoy M.O.; Catchatourian R.; Vadakara J.; Rosti V.; Hexner E.; Kremyanskaya M.; Sandy L.; Tripodi J.; Najfeld V.; Farnoud N.; Salama M.E.; Weinberg R.S.; Rampal R.; Goldberg J.D.; Mesa R.; Dueck A.C.; Hoffman R.. - In: LEUKEMIA. - ISSN 0887-6924. - ELETTRONICO. - (2019), pp. 1-5. [10.1038/s41375-019-0524-7]
A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis
Vannucchi A. M.;
2019
Abstract
we report the outcomes of the 20 SVT paztients who were treated with PEGFile | Dimensione | Formato | |
---|---|---|---|
1mascarenhas2019.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
638.51 kB
Formato
Adobe PDF
|
638.51 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.